Symptoms and diagnosis of Hurler syndrome (MPS I-H)

Hurler syndrome (MPS I-H) usually starts in the first year of life, but early signs are often subtle and can be mistaken for common childhood problems. As glycosaminoglycans (GAGs) accumulate, children develop a recognisable combination of facial, skeletal, cardiac, respiratory and developmental features. Early recognition and prompt diagnosis are critical, because timely haematopoietic stem cell transplantation (HSCT) offers the best chance of preserving brain function and improving long term outcomes.

This section explains what to look for, when to suspect Hurler syndrome, and how the diagnosis is confirmed, for both families and healthcare professionals.

What you'll find in "Symptoms & diagnosis"

This section provides comprehensive information on recognising and diagnosing Hurler syndrome:

Early signs and symptoms in babies

Many babies with Hurler syndrome appear well at birth. The first signs often develop gradually over the first 6–12 months, and families or clinicians may initially attribute them to more common childhood issues. Recognising patterns, rather than individual symptoms in isolation, is key.

 

Recurrent infections

Frequent ear, nose, throat or chest infections.

Umbilical or inguinal hernias

Persistent or recurrent bulges at the belly button or groin.

Coarse facial features

Gradually developing fuller lips, broad nasal bridge and enlarged tongue (macroglossia).

Increasing head size

Sometimes with a broad forehead.

Developmental delay

Slow attainment of motor or language milestones, often subtle at first.

Stiff joints

Reduced range of movement, difficulty fully straightening elbows or fingers.

For parents

Having one or two of these features does not mean a child definitely has Hurler syndrome. However, if several are present together, especially with developmental concerns, it is reasonable to ask for referral to a metabolic or genetics specialist.

Symptom Pattern from Infancy to Early Childhood

Symptom pattern from infancy to early childhood

Hurler syndrome is progressive. Without effective treatment, symptoms become more obvious and more numerous between ages 1 and 4 years. Understanding this typical pattern helps clinicians recognise the disease earlier and helps families make sense of changes they are seeing.

Infancy

(0-12 months)

  • Hernias, frequent infections, emerging coarse facial features
  • Mild liver and spleen enlargement
  • Subtle developmental delay

Toddler years

(1-3 years)

  • Worsening coarse facial features and macroglossia
  • Increasing joint stiffness and reduced mobility
  • Enlarged abdomen, clear hepatosplenomegaly
  • Noisy breathing, snoring and possible sleep apnoea
  • More obvious delay in language and motor skills

Early childhood

(3-5 years) if untreated

  • Progressive loss of acquired skills (cognitive regression)
  • Increasing skeletal deformities (spine curvature, hip problems)
  • Worsening heart valve disease and respiratory compromise
Clinical Suspicion Section

When should clinicians suspect Hurler syndrome?

Hurler syndrome is rare, but certain combinations of features should prompt consideration of MPS I-H in a baby or young child. Early diagnosis is especially important because:

  • HSCT is most effective when performed before significant neurocognitive decline.
  • ERT and supportive care are safer and more effective when started before severe cardiorespiratory compromise.
Practical takeaway

If the clinical picture suggests MPS I-H, refer early to a metabolic centre. A short discussion with specialists can reduce delays to diagnosis and treatment.

Red flag combinations that should trigger metabolic referral

Coarse facial features plus hepatosplenomegaly plus hernias.

Joint stiffness or contractures in a toddler without inflammation, especially with growth delay.

Developmental delay plus consistent somatic features (e.g. stiff joints, hernias, recurrent infections, noisy breathing).

Unexplained thoracolumbar gibbus or other spinal deformity in a young child.

If Hurler syndrome is suspected, do not wait for every test result before contacting a metabolic centre. Early discussion with a specialist team can shorten the time to diagnosis and treatment.

Diagnostic Tests Section

Diagnostic tests: from suspicion to confirmation

Diagnosis of Hurler syndrome is based on a combination of clinical assessment and laboratory tests. In most settings, the steps include:

Clinical assessment

Detailed history, family history and physical examination focusing on multisystem involvement.

Screening tests

Urine GAGs: elevated glycosaminoglycans suggest an MPS disorder, though normal results do not completely exclude MPS I in young infants or attenuated disease. Basic blood tests and imaging as needed (e.g. skeletal survey, echocardiogram).

Confirmatory tests

Enzyme assay: measurement of alpha L iduronidase activity in leukocytes, fibroblasts or dried blood spots. Markedly reduced or absent activity confirms MPS I.

Molecular genetic testing: sequencing of the IDUA gene to identify pathogenic variants, confirm diagnosis and support carrier testing and family planning.

In some regions, an initial low IDUA result from newborn screening is the first indication of MPS I, followed by confirmatory enzyme and genetic testing to distinguish severe from attenuated forms.

Role of newborn screening in MPS I

Newborn screening for MPS I is now included in screening panels in several countries. For families, this means that a baby may be flagged before any visible symptoms appear. For clinicians, it introduces new challenges: deciding how urgently to assess the child, how to predict severity and how to communicate uncertainty if the phenotype is not yet clear.

Infants with clearly severe MPS I-H on confirmatory testing should be referred immediately to a specialist centre for HSCT assessment.
Babies with attenuated or uncertain phenotypes need careful monitoring and genetic counselling, even if urgent HSCT is not indicated.

Early detection by screening offers the best chance to preserve neurocognitive function in Hurler syndrome, but robust algorithms for predicting severity are still evolving.

Differential diagnosis

Several conditions can share some features with Hurler syndrome, especially in early stages, including other mucopolysaccharidoses, mucolipidoses, storage disorders, skeletal dysplasias and non-specific developmental delay. Distinguishing features often include:

  • • Pattern of skeletal changes on imaging (dysostosis multiplex vs other patterns).
  • • Urine GAG profile distinguishing MPS I from other MPS types.
  • • Specific enzyme assays and genetic tests.

Although detailed differential diagnosis is mainly for clinicians, families may find it reassuring to know that a structured approach exists and that a precise diagnosis is usually achievable once a child is referred to the right specialist team.

If you are concerned about symptoms

If you are a parent or caregiver and are worried that your child might have Hurler syndrome or another inherited condition, you can:

  • Talk to your GP or paediatrician about the symptoms you have noticed.
  • Bring photos or notes showing how features have changed over time.
  • Ask whether a referral to a metabolic or genetics clinic is appropriate.
  • Share any family history of early childhood illness, developmental problems or known genetic conditions.

Reassurance: Most children with features like hernias, frequent infections or developmental delay do not have Hurler syndrome. However, if you feel something is being missed, it is reasonable to request a specialist opinion.

First steps when Hurler syndrome is suspected

Practical next steps for healthcare professionals:

  • Take a focused history (development, infections, hernias, family history, consanguinity).
  • Perform a full physical examination with attention to facial features, abdomen, joints, spine, heart and respiratory status.
  • Arrange baseline investigations (e.g. full blood count, liver function, abdominal ultrasound, echocardiography, X-rays) as appropriate.
  • Order urine GAGs and alpha L iduronidase enzyme assay according to local protocols.
  • Contact or refer to a regional inherited metabolic disease centre without delay.

Note: Exact test ordering pathways will depend on national guidelines and local laboratory availability.

Key Points Section

Key points about symptoms and diagnosis

1

Hurler syndrome usually starts in the first year of life, with a combination of recurrent infections, hernias, coarse facial features and subtle developmental delay.

2

The condition is progressive; symptoms become more obvious and severe between 1 and 4 years if untreated.

3

Early recognition and rapid referral to a metabolic centre are essential, because HSCT is most effective when performed before major neurocognitive decline.

4

Diagnosis is confirmed by low alpha L iduronidase activity and pathogenic IDUA variants, supported by urine GAGs and clinical findings.

5

Newborn screening is increasingly important for early detection, but clinical vigilance remains vital wherever screening is not available.

What to read next

Early signs and red flags

What to look for in babies and toddlers

How Hurler syndrome is diagnosed

Tests, pathways and confirmatory steps

Newborn screening for MPS I

How screening works and what results mean

Treatments and care

What happens after diagnosis

Scroll to Top